SPECT/CT localization of oral radioiodine activity
Open Access
- 1 December 2013
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Nuclear Medicine Communications
- Vol. 34 (12), 1216-1222
- https://doi.org/10.1097/mnm.0000000000000004
Abstract
We sought to further localize radioiodine activity in the mouth on post-thyroid cancer therapy imaging using single-photon emission computed tomography/computed tomography (SPECT/CT). We retrospectively reviewed all patients (58) who underwent thyroid cancer therapy with iodine-131 (131I) at our institution from August 2009 to March 2011 whose post-therapy radioiodine imaging included neck SPECT/CT. A small group (six) of diagnostic 123I scans including SPECT/CT was also reviewed. Separately, we performed in-vitro 131I (sodium iodide) binding assays with amalgam and Argenco HP 77 (77% dental gold alloy) as proof of principle for these interactions. Of the 58 post-therapy patients, 45 (78%) had undergone metallic dental restorations, and of them 41 (91%) demonstrated oral 131I activity localizing preferentially to those restorations. It was observed that radioiodine also localized to other dental restorations and to orthodontic hardware. Gum-line activity in edentulous patients suggests radioiodine interaction with denture adhesive. In vitro, dental amalgam and Argenco HP 77 bound 131I in a time-dependent manner over 1–16 days of exposure. Despite subsequent washings with normal saline, significant 131I activity (maximally 12% for amalgam and 68% for Argenco HP 77) was retained by these metals. Subsequent soaking in a saturated solution of potassium iodide partially displaced 131I from amalgam, with near-total displacement of 131I from Argenco HP 77. SPECT/CT shows that radioiodine in the oral cavity localizes to metallic dental restorations. Furthermore, in-vitro studies demonstrate partially reversible binding of 131I to common dental metals.Keywords
This publication has 20 references indexed in Scilit:
- Radioiodine Scintigraphy with SPECT/CT: An Important Diagnostic Tool for Thyroid Cancer Staging and Risk StratificationJournal of Nuclear Medicine, 2012
- The Effect of Posttherapy 131I SPECT/CT on Risk Classification and Management of Patients with Differentiated Thyroid CancerJournal of Nuclear Medicine, 2010
- Hybrid SPECT–CT and PET–CT imaging of differentiated thyroid carcinomaThe British Journal of Radiology, 2009
- Hybrid Imaging (SPECT/CT and PET/CT): Improving Therapeutic DecisionsSeminars in Nuclear Medicine, 2009
- Posttherapy I-131 Thymic Uptake Demonstrated with SPECT/CT in a Young Girl with Papillary Thyroid CarcinomaThyroid®, 2008
- SPECT/CTJournal of Nuclear Medicine, 2008
- Iodine-131 Uptake in a Menstruating Uterus: Value of SPECT/CT in Distinguishing Benign and Metastatic Iodine-Positive LesionsThyroid®, 2007
- Benign Struma Ovarii in a Patient With Invasive Papillary Thyroid Cancer: Detection with I-131 SPECT-CTClinical Nuclear Medicine, 2007
- Usefulness of SPECT/CT in the Diagnosis of Intrathoracic Goiter versus Metastases From Cancer of the BreastClinical Nuclear Medicine, 2007
- Diagnostic Significance of Dental History in the Clinical Evaluation of Patients with Thyroid CarcinomaClinical Nuclear Medicine, 1992